| 0 |
AMNIOTIC FLUID INDEX INCREASED |
15 |
0.8333 |
| 1 |
GENITAL INFECTION VIRAL |
11 |
0.4783 |
| 2 |
BRONCHOLITHIASIS |
9 |
0.2903 |
| 3 |
HEART SOUNDS |
20 |
0.2083 |
| 4 |
OCCUPATIONAL ASTHMA |
8 |
0.1379 |
| 5 |
HYPERKALIURIA |
6 |
0.1111 |
| 6 |
TOTAL LUNG CAPACITY INCREASED |
24 |
0.0882 |
| 7 |
PROLONGED EXPIRATION |
21 |
0.0802 |
| 8 |
CONGENITAL MEGAURETER |
12 |
0.0622 |
| 9 |
ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME |
32 |
0.0612 |
| 10 |
ATHEROEMBOLISM |
8 |
0.0593 |
| 11 |
FOETAL MACROSOMIA |
15 |
0.0540 |
| 12 |
LUNG DIFFUSION DISORDER |
8 |
0.0510 |
| 13 |
LEFT-TO-RIGHT CARDIAC SHUNT |
15 |
0.0508 |
| 14 |
KIDNEY DUPLEX |
12 |
0.0500 |
| 15 |
RESPIRATORY GAS EXCHANGE DISORDER |
18 |
0.0485 |
| 16 |
LYMPH NODE CALCIFICATION |
9 |
0.0464 |
| 17 |
BREATH SOUNDS |
6 |
0.0438 |
| 18 |
DOSE CALCULATION ERROR |
25 |
0.0427 |
| 19 |
MUCOSAL HYPERTROPHY |
6 |
0.0405 |
| 20 |
BRONCHOMALACIA |
5 |
0.0379 |
| 21 |
REVERSIBLE AIRWAYS OBSTRUCTION |
15 |
0.0295 |
| 22 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
444 |
0.0261 |
| 23 |
DEVICE PROGRAMMING ERROR |
8 |
0.0252 |
| 24 |
VITAL CAPACITY DECREASED |
11 |
0.0246 |
| 25 |
BRONCHIAL OBSTRUCTION |
34 |
0.0242 |
| 26 |
HEART RATE |
8 |
0.0230 |
| 27 |
ACQUIRED DIAPHRAGMATIC EVENTRATION |
8 |
0.0225 |
| 28 |
BRONCHIAL WALL THICKENING |
16 |
0.0223 |
| 29 |
MOTOR DEVELOPMENTAL DELAY |
12 |
0.0208 |
| 30 |
OBSTRUCTIVE AIRWAYS DISORDER |
227 |
0.0204 |
| 31 |
LUNG HYPERINFLATION |
17 |
0.0198 |
| 32 |
INTENSIVE CARE UNIT ACQUIRED WEAKNESS |
7 |
0.0184 |
| 33 |
SPIROMETRY ABNORMAL |
11 |
0.0184 |
| 34 |
DEPENDENCE ON OXYGEN THERAPY |
9 |
0.0183 |
| 35 |
SPUTUM PURULENT |
12 |
0.0182 |
| 36 |
PEAK EXPIRATORY FLOW RATE DECREASED |
8 |
0.0182 |
| 37 |
CONGENITAL HYDRONEPHROSIS |
12 |
0.0168 |
| 38 |
ASTHMATIC CRISIS |
60 |
0.0164 |
| 39 |
VOCAL CORD DYSFUNCTION |
8 |
0.0162 |
| 40 |
BLOOD IMMUNOGLOBULIN E INCREASED |
39 |
0.0161 |
| 41 |
OESOPHAGEAL DILATATION |
7 |
0.0158 |
| 42 |
ALLERGY TO PLANTS |
7 |
0.0153 |
| 43 |
WHEEZING |
846 |
0.0143 |
| 44 |
PRODUCT DELIVERY MECHANISM ISSUE |
76 |
0.0141 |
| 45 |
FULL BLOOD COUNT ABNORMAL |
145 |
0.0137 |
| 46 |
FEMALE STERILISATION |
7 |
0.0136 |
| 47 |
ASTHMA |
1510 |
0.0133 |
| 48 |
TOTAL LUNG CAPACITY DECREASED |
21 |
0.0131 |
| 49 |
BLOOD COUNT ABNORMAL |
195 |
0.0128 |
| 50 |
INFUSION SITE DISCHARGE |
22 |
0.0125 |
| 51 |
BRONCHIAL HYPERREACTIVITY |
15 |
0.0125 |
| 52 |
EOSINOPHIL COUNT INCREASED |
103 |
0.0123 |
| 53 |
VULVAL DISORDER |
8 |
0.0121 |
| 54 |
PNEUMONIA STREPTOCOCCAL |
13 |
0.0119 |
| 55 |
SPUTUM DISCOLOURED |
112 |
0.0118 |
| 56 |
BRONCHIAL SECRETION RETENTION |
15 |
0.0118 |
| 57 |
BRONCHIECTASIS |
78 |
0.0116 |
| 58 |
STRESS URINARY INCONTINENCE |
12 |
0.0112 |
| 59 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
570 |
0.0109 |
| 60 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
520 |
0.0108 |
| 61 |
MULTIPLE ALLERGIES |
79 |
0.0101 |
| 62 |
OXYGEN CONSUMPTION DECREASED |
6 |
0.0099 |
| 63 |
POST-ACUTE COVID-19 SYNDROME |
12 |
0.0097 |
| 64 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
14 |
0.0096 |
| 65 |
ADRENAL SUPPRESSION |
8 |
0.0095 |
| 66 |
EOSINOPHIL COUNT ABNORMAL |
7 |
0.0094 |
| 67 |
BREATH SOUNDS ABNORMAL |
46 |
0.0093 |
| 68 |
CLOSTRIDIUM TEST POSITIVE |
20 |
0.0091 |
| 69 |
PULMONARY FUNCTION TEST ABNORMAL |
14 |
0.0090 |
| 70 |
EROSIVE DUODENITIS |
7 |
0.0088 |
| 71 |
RHINITIS ALLERGIC |
38 |
0.0085 |
| 72 |
GENITAL HERPES |
13 |
0.0085 |
| 73 |
RESPIRATION ABNORMAL |
58 |
0.0084 |
| 74 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
581 |
0.0082 |
| 75 |
DUST ALLERGY |
8 |
0.0082 |
| 76 |
NASAL POLYPS |
40 |
0.0081 |
| 77 |
INFUSION SITE BRUISING |
17 |
0.0079 |
| 78 |
NOCTURNAL DYSPNOEA |
10 |
0.0078 |
| 79 |
PULMONARY FUNCTION TEST DECREASED |
34 |
0.0078 |
| 80 |
EMPHYSEMA |
78 |
0.0077 |
| 81 |
RESPIRATORY TRACT IRRITATION |
8 |
0.0077 |
| 82 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
7 |
0.0076 |
| 83 |
SPUTUM INCREASED |
16 |
0.0074 |
| 84 |
PRODUCTIVE COUGH |
346 |
0.0072 |
| 85 |
RHONCHI |
10 |
0.0072 |
| 86 |
DRUG DELIVERY SYSTEM ISSUE |
14 |
0.0071 |
| 87 |
OXYGEN SATURATION ABNORMAL |
20 |
0.0070 |
| 88 |
UPPER-AIRWAY COUGH SYNDROME |
58 |
0.0070 |
| 89 |
HYPOCHROMIC ANAEMIA |
7 |
0.0069 |
| 90 |
RALES |
40 |
0.0069 |
| 91 |
SPONTANEOUS HAEMORRHAGE |
7 |
0.0068 |
| 92 |
CHOLANGIOCARCINOMA |
10 |
0.0067 |
| 93 |
RESPIRATORY SYMPTOM |
19 |
0.0067 |
| 94 |
VOCAL CORD DISORDER |
13 |
0.0066 |
| 95 |
SEASONAL ALLERGY |
92 |
0.0065 |
| 96 |
DEVICE INFUSION ISSUE |
16 |
0.0064 |
| 97 |
LUNG OPACITY |
17 |
0.0064 |
| 98 |
INFUSION SITE MASS |
7 |
0.0064 |
| 99 |
PAINFUL RESPIRATION |
15 |
0.0062 |
| 100 |
THROAT CLEARING |
23 |
0.0061 |
| 101 |
DYSPNOEA EXERTIONAL |
230 |
0.0061 |
| 102 |
MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED |
10 |
0.0060 |
| 103 |
RESTRICTIVE PULMONARY DISEASE |
7 |
0.0060 |
| 104 |
SENSE OF OPPRESSION |
7 |
0.0059 |
| 105 |
PNEUMONIA PSEUDOMONAL |
9 |
0.0059 |
| 106 |
INFUSION SITE RASH |
8 |
0.0058 |
| 107 |
SECRETION DISCHARGE |
73 |
0.0058 |
| 108 |
INFUSION SITE HAEMORRHAGE |
19 |
0.0058 |
| 109 |
BRONCHITIS CHRONIC |
14 |
0.0057 |
| 110 |
DEPRESSIVE SYMPTOM |
20 |
0.0057 |
| 111 |
INFUSION SITE SWELLING |
35 |
0.0056 |
| 112 |
SNORING |
21 |
0.0055 |
| 113 |
PRURITUS GENITAL |
13 |
0.0055 |
| 114 |
OXYGEN CONSUMPTION INCREASED |
13 |
0.0054 |
| 115 |
OESOPHAGEAL SPASM |
10 |
0.0054 |
| 116 |
LUNG CONSOLIDATION |
15 |
0.0054 |
| 117 |
LIP INJURY |
7 |
0.0053 |
| 118 |
CHRONIC SINUSITIS |
20 |
0.0053 |
| 119 |
PNEUMONIA FUNGAL |
21 |
0.0053 |
| 120 |
HALO VISION |
6 |
0.0053 |
| 121 |
MYCOBACTERIAL INFECTION |
9 |
0.0052 |
| 122 |
PULMONARY PAIN |
15 |
0.0051 |
| 123 |
CARBON DIOXIDE INCREASED |
7 |
0.0051 |
| 124 |
MITRAL VALVE DISEASE |
9 |
0.0051 |
| 125 |
ESSENTIAL HYPERTENSION |
9 |
0.0049 |
| 126 |
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS |
10 |
0.0049 |
| 127 |
INFUSION SITE WARMTH |
6 |
0.0049 |
| 128 |
INFUSION SITE ERYTHEMA |
41 |
0.0049 |
| 129 |
NASAL OBSTRUCTION |
9 |
0.0048 |
| 130 |
RESPIRATORY TRACT CONGESTION |
75 |
0.0047 |
| 131 |
INCREASED BRONCHIAL SECRETION |
12 |
0.0047 |
| 132 |
MONOCYTE COUNT INCREASED |
17 |
0.0047 |
| 133 |
PULMONARY MASS |
69 |
0.0046 |
| 134 |
RHINITIS |
37 |
0.0046 |
| 135 |
CARDIAC MURMUR |
39 |
0.0045 |
| 136 |
INFUSION SITE PRURITUS |
14 |
0.0044 |
| 137 |
SARCOIDOSIS |
21 |
0.0044 |
| 138 |
CREPITATIONS |
13 |
0.0044 |
| 139 |
MAST CELL ACTIVATION SYNDROME |
6 |
0.0043 |
| 140 |
OXYGEN THERAPY |
7 |
0.0043 |
| 141 |
OBSTRUCTION |
17 |
0.0043 |
| 142 |
HYPERVOLAEMIA |
21 |
0.0042 |
| 143 |
FORCED EXPIRATORY VOLUME DECREASED |
12 |
0.0042 |
| 144 |
RESPIRATORY TRACT INFECTION |
109 |
0.0042 |
| 145 |
SPEECH DISORDER DEVELOPMENTAL |
12 |
0.0042 |
| 146 |
CHOKING |
81 |
0.0041 |
| 147 |
CHRONIC RESPIRATORY FAILURE |
5 |
0.0041 |
| 148 |
DYSPNOEA |
2340 |
0.0041 |
| 149 |
BLOOD IMMUNOGLOBULIN G INCREASED |
5 |
0.0041 |
| 150 |
HAEMATOLOGICAL INFECTION |
10 |
0.0041 |
| 151 |
MIDDLE EAR EFFUSION |
9 |
0.0041 |
| 152 |
BLOOD IMMUNOGLOBULIN G DECREASED |
10 |
0.0040 |
| 153 |
GLOSSITIS |
14 |
0.0039 |
| 154 |
LOWER RESPIRATORY TRACT INFECTION |
178 |
0.0039 |
| 155 |
COUGH |
1093 |
0.0039 |
| 156 |
RENAL MASS |
8 |
0.0039 |
| 157 |
RESPIRATORY TRACT INFECTION VIRAL |
9 |
0.0039 |
| 158 |
MEAN CELL HAEMOGLOBIN DECREASED |
7 |
0.0038 |
| 159 |
APHONIA |
53 |
0.0038 |
| 160 |
EXERCISE TOLERANCE DECREASED |
21 |
0.0036 |
| 161 |
INFUSION SITE PAIN |
47 |
0.0036 |
| 162 |
APPETITE DISORDER |
24 |
0.0036 |
| 163 |
SLEEP APNOEA SYNDROME |
69 |
0.0036 |
| 164 |
PNEUMONIA BACTERIAL |
33 |
0.0036 |
| 165 |
CHEST X-RAY ABNORMAL |
11 |
0.0036 |
| 166 |
OESOPHAGEAL PAIN |
14 |
0.0035 |
| 167 |
POLYP |
23 |
0.0035 |
| 168 |
CHEST DISCOMFORT |
358 |
0.0035 |
| 169 |
POLYMYALGIA RHEUMATICA |
11 |
0.0035 |
| 170 |
DRY THROAT |
35 |
0.0034 |
| 171 |
EAR PRURITUS |
12 |
0.0034 |
| 172 |
GINGIVAL DISORDER |
13 |
0.0034 |
| 173 |
OPHTHALMIC HERPES ZOSTER |
6 |
0.0033 |
| 174 |
NASAL OEDEMA |
6 |
0.0033 |
| 175 |
CANDIDA INFECTION |
56 |
0.0033 |
| 176 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
28 |
0.0032 |
| 177 |
NASAL CONGESTION |
186 |
0.0032 |
| 178 |
RIB FRACTURE |
65 |
0.0032 |
| 179 |
BRONCHIOLITIS |
11 |
0.0031 |
| 180 |
DYSPNOEA AT REST |
9 |
0.0031 |
| 181 |
HYPERVENTILATION |
18 |
0.0031 |
| 182 |
CHOKING SENSATION |
17 |
0.0031 |
| 183 |
INSURANCE ISSUE |
47 |
0.0031 |
| 184 |
LUNG NEOPLASM MALIGNANT |
126 |
0.0031 |
| 185 |
STRIDOR |
9 |
0.0031 |
| 186 |
BRONCHITIS |
224 |
0.0030 |
| 187 |
OXYGEN SATURATION DECREASED |
170 |
0.0030 |
| 188 |
LUNG DISORDER |
144 |
0.0029 |
| 189 |
URINE FLOW DECREASED |
7 |
0.0029 |
| 190 |
UPPER RESPIRATORY TRACT INFECTION |
135 |
0.0029 |
| 191 |
PNEUMONIA |
934 |
0.0029 |
| 192 |
BRONCHOSPASM |
41 |
0.0029 |
| 193 |
ORAL DISCOMFORT |
39 |
0.0028 |
| 194 |
EOSINOPHILIA |
49 |
0.0028 |
| 195 |
HAEMOPTYSIS |
77 |
0.0028 |
| 196 |
MIDDLE INSOMNIA |
51 |
0.0027 |
| 197 |
INFUSION SITE EXTRAVASATION |
17 |
0.0027 |
| 198 |
BODY TEMPERATURE ABNORMAL |
5 |
0.0027 |
| 199 |
IRON DEFICIENCY |
12 |
0.0027 |
| 200 |
SPINAL STENOSIS |
11 |
0.0027 |
| 201 |
THROAT IRRITATION |
119 |
0.0026 |
| 202 |
HAEMATOCRIT INCREASED |
6 |
0.0026 |
| 203 |
ARTERIAL DISORDER |
5 |
0.0026 |
| 204 |
DYSPHONIA |
153 |
0.0026 |
| 205 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
7 |
0.0026 |
| 206 |
OESOPHAGEAL DISORDER |
10 |
0.0026 |
| 207 |
EXTRA DOSE ADMINISTERED |
105 |
0.0026 |
| 208 |
INCORRECT DRUG ADMINISTRATION RATE |
11 |
0.0026 |
| 209 |
RESPIRATORY DISORDER |
77 |
0.0026 |
| 210 |
PRODUCT QUALITY ISSUE |
349 |
0.0026 |
| 211 |
RHINOVIRUS INFECTION |
10 |
0.0026 |
| 212 |
ABDOMINAL WALL HAEMATOMA |
5 |
0.0026 |
| 213 |
ACUTE RESPIRATORY FAILURE |
49 |
0.0025 |
| 214 |
DRUG DELIVERY SYSTEM MALFUNCTION |
13 |
0.0025 |
| 215 |
RED BLOOD CELL COUNT INCREASED |
7 |
0.0025 |
| 216 |
EOSINOPHIL COUNT DECREASED |
6 |
0.0025 |
| 217 |
URINARY HESITATION |
6 |
0.0025 |
| 218 |
INTENTIONAL DEVICE MISUSE |
11 |
0.0025 |
| 219 |
SKIN LACERATION |
27 |
0.0025 |
| 220 |
WRONG DOSE |
6 |
0.0025 |
| 221 |
SINUSITIS |
254 |
0.0025 |
| 222 |
FRUSTRATION TOLERANCE DECREASED |
20 |
0.0025 |
| 223 |
LYMPHOEDEMA |
17 |
0.0025 |
| 224 |
CONJUNCTIVITIS |
45 |
0.0024 |
| 225 |
SUFFOCATION FEELING |
6 |
0.0024 |
| 226 |
DEVICE POWER SOURCE ISSUE |
7 |
0.0024 |
| 227 |
OROPHARYNGEAL PAIN |
220 |
0.0024 |
| 228 |
SINUS CONGESTION |
32 |
0.0024 |
| 229 |
TONGUE DISCOMFORT |
10 |
0.0024 |
| 230 |
FLANK PAIN |
22 |
0.0023 |
| 231 |
INFUSION SITE REACTION |
7 |
0.0023 |
| 232 |
DECREASED ACTIVITY |
25 |
0.0023 |
| 233 |
ATELECTASIS |
22 |
0.0023 |
| 234 |
IDIOPATHIC PULMONARY FIBROSIS |
9 |
0.0023 |
| 235 |
PULMONARY CONGESTION |
30 |
0.0023 |
| 236 |
MACULAR DEGENERATION |
27 |
0.0023 |
| 237 |
OESOPHAGEAL CANDIDIASIS |
9 |
0.0023 |
| 238 |
INFLUENZA |
251 |
0.0022 |
| 239 |
VIRAL INFECTION |
74 |
0.0022 |
| 240 |
SINUS DISORDER |
44 |
0.0022 |
| 241 |
PSEUDOMONAS INFECTION |
19 |
0.0022 |
| 242 |
BLOOD LOSS ANAEMIA |
5 |
0.0022 |
| 243 |
PNEUMONIA VIRAL |
7 |
0.0022 |
| 244 |
HAEMOGLOBIN INCREASED |
10 |
0.0022 |
| 245 |
EAR DISORDER |
10 |
0.0022 |
| 246 |
PNEUMONITIS |
59 |
0.0022 |
| 247 |
PHARYNGEAL SWELLING |
21 |
0.0021 |
| 248 |
RHINORRHOEA |
138 |
0.0021 |
| 249 |
THROAT CANCER |
9 |
0.0021 |
| 250 |
ORAL CANDIDIASIS |
28 |
0.0021 |
| 251 |
SUSPECTED COVID-19 |
7 |
0.0021 |
| 252 |
NEAR DEATH EXPERIENCE |
7 |
0.0021 |
| 253 |
GASTROINTESTINAL INFECTION |
19 |
0.0021 |
| 254 |
WRIST FRACTURE |
25 |
0.0021 |
| 255 |
THYROID MASS |
8 |
0.0021 |
| 256 |
PNEUMOTHORAX |
33 |
0.0021 |
| 257 |
BILIARY COLIC |
6 |
0.0021 |
| 258 |
ADRENAL INSUFFICIENCY |
25 |
0.0021 |
| 259 |
ILLNESS |
212 |
0.0021 |
| 260 |
ABNORMAL LOSS OF WEIGHT |
14 |
0.0021 |
| 261 |
LEFT VENTRICULAR FAILURE |
7 |
0.0020 |
| 262 |
COVID-19 PNEUMONIA |
24 |
0.0020 |
| 263 |
HYPOPNOEA |
7 |
0.0020 |
| 264 |
BLOOD TEST ABNORMAL |
28 |
0.0020 |
| 265 |
INTRACRANIAL ANEURYSM |
8 |
0.0020 |
| 266 |
KIDNEY INFECTION |
39 |
0.0020 |
| 267 |
CYSTIC FIBROSIS |
11 |
0.0020 |
| 268 |
GLAUCOMA |
38 |
0.0020 |
| 269 |
RETCHING |
42 |
0.0020 |
| 270 |
MUSCLE STRAIN |
17 |
0.0020 |
| 271 |
COVID-19 |
344 |
0.0020 |
| 272 |
GASTROOESOPHAGEAL REFLUX DISEASE |
157 |
0.0019 |
| 273 |
INCREASED UPPER AIRWAY SECRETION |
10 |
0.0019 |
| 274 |
FOOD ALLERGY |
15 |
0.0019 |
| 275 |
PRODUCT DISTRIBUTION ISSUE |
18 |
0.0019 |
| 276 |
CONCUSSION |
15 |
0.0019 |
| 277 |
SOCIAL PROBLEM |
8 |
0.0019 |
| 278 |
PELVIC FRACTURE |
15 |
0.0019 |
| 279 |
CAROTID ARTERY OCCLUSION |
7 |
0.0019 |
| 280 |
NASAL DRYNESS |
12 |
0.0019 |
| 281 |
LEFT VENTRICULAR HYPERTROPHY |
8 |
0.0019 |
| 282 |
SKIN EROSION |
6 |
0.0019 |
| 283 |
EYE DISORDER |
61 |
0.0019 |
| 284 |
PLEURISY |
11 |
0.0019 |
| 285 |
HEPATIC LESION |
8 |
0.0018 |
| 286 |
HORDEOLUM |
8 |
0.0018 |
| 287 |
POOR VENOUS ACCESS |
19 |
0.0018 |
| 288 |
PULMONARY THROMBOSIS |
20 |
0.0018 |
| 289 |
SNEEZING |
41 |
0.0018 |
| 290 |
HYPOXIA |
64 |
0.0018 |
| 291 |
UPPER LIMB FRACTURE |
36 |
0.0018 |
| 292 |
HEART RATE ABNORMAL |
10 |
0.0018 |
| 293 |
PRODUCT ADMINISTRATION INTERRUPTED |
14 |
0.0018 |
| 294 |
OROPHARYNGEAL DISCOMFORT |
16 |
0.0018 |
| 295 |
RENAL CYST |
14 |
0.0018 |
| 296 |
TOOTH INFECTION |
23 |
0.0017 |
| 297 |
SKIN ATROPHY |
10 |
0.0017 |
| 298 |
AORTIC ANEURYSM |
13 |
0.0017 |
| 299 |
SKIN ABRASION |
8 |
0.0017 |
| 300 |
COMPRESSION FRACTURE |
9 |
0.0017 |
| 301 |
PRODUCT PRESCRIBING ERROR |
40 |
0.0017 |
| 302 |
CYSTITIS |
53 |
0.0017 |
| 303 |
EAR DISCOMFORT |
17 |
0.0017 |
| 304 |
CRANIOCEREBRAL INJURY |
5 |
0.0017 |
| 305 |
SCLERODERMA |
6 |
0.0016 |
| 306 |
LUNG NEOPLASM |
7 |
0.0016 |
| 307 |
PULMONARY HYPERTENSION |
34 |
0.0016 |
| 308 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
5 |
0.0016 |
| 309 |
BLOOD BLISTER |
5 |
0.0016 |
| 310 |
BRAIN FOG |
25 |
0.0016 |
| 311 |
SARS-COV-2 TEST POSITIVE |
21 |
0.0016 |
| 312 |
DRY MOUTH |
129 |
0.0016 |
| 313 |
DERMATITIS CONTACT |
18 |
0.0016 |
| 314 |
EAR INFECTION |
42 |
0.0016 |
| 315 |
PARANASAL SINUS HYPERSECRETION |
6 |
0.0016 |
| 316 |
BILE DUCT STONE |
5 |
0.0016 |
| 317 |
OBESITY |
25 |
0.0016 |
| 318 |
CATARACT |
93 |
0.0016 |
| 319 |
HAEMOGLOBIN ABNORMAL |
10 |
0.0016 |
| 320 |
ABDOMINAL HERNIA |
7 |
0.0015 |
| 321 |
GLUCOSE TOLERANCE IMPAIRED |
9 |
0.0015 |
| 322 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
26 |
0.0015 |
| 323 |
SINUS HEADACHE |
9 |
0.0015 |
| 324 |
ANXIETY DISORDER |
5 |
0.0015 |
| 325 |
FLUID RETENTION |
76 |
0.0015 |
| 326 |
FOOD POISONING |
8 |
0.0015 |
| 327 |
FOETAL GROWTH RESTRICTION |
9 |
0.0015 |
| 328 |
WRONG PRODUCT ADMINISTERED |
10 |
0.0015 |
| 329 |
NASOPHARYNGITIS |
271 |
0.0015 |
| 330 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
8 |
0.0015 |
| 331 |
TRIGGER FINGER |
6 |
0.0015 |
| 332 |
DEVICE MALFUNCTION |
103 |
0.0015 |
| 333 |
HYPOVOLAEMIC SHOCK |
7 |
0.0015 |
| 334 |
RESPIRATORY DISTRESS |
40 |
0.0014 |
| 335 |
SPINAL FRACTURE |
29 |
0.0014 |
| 336 |
ANAL INCONTINENCE |
13 |
0.0014 |
| 337 |
GASTROENTERITIS VIRAL |
26 |
0.0014 |
| 338 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
6 |
0.0014 |
| 339 |
HYPERPYREXIA |
6 |
0.0014 |
| 340 |
QUALITY OF LIFE DECREASED |
19 |
0.0014 |
| 341 |
ESCHERICHIA URINARY TRACT INFECTION |
6 |
0.0014 |
| 342 |
HAND FRACTURE |
10 |
0.0014 |
| 343 |
BLADDER DISORDER |
14 |
0.0014 |
| 344 |
BLOOD PRESSURE ABNORMAL |
28 |
0.0014 |
| 345 |
JOINT INJURY |
30 |
0.0014 |
| 346 |
LIMB INJURY |
38 |
0.0014 |
| 347 |
ANGINA PECTORIS |
40 |
0.0014 |
| 348 |
NASAL DISCOMFORT |
11 |
0.0014 |
| 349 |
IMMOBILE |
6 |
0.0014 |
| 350 |
SOMNAMBULISM |
9 |
0.0014 |
| 351 |
PHYSICAL DISABILITY |
6 |
0.0014 |
| 352 |
PULMONARY FIBROSIS |
26 |
0.0014 |
| 353 |
DEVICE DELIVERY SYSTEM ISSUE |
37 |
0.0014 |
| 354 |
HYPERCHOLESTEROLAEMIA |
13 |
0.0013 |
| 355 |
HERNIA |
26 |
0.0013 |
| 356 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
240 |
0.0013 |
| 357 |
ATRIAL FIBRILLATION |
129 |
0.0013 |
| 358 |
EXPOSURE VIA SKIN CONTACT |
34 |
0.0013 |
| 359 |
EYE OPERATION |
6 |
0.0013 |
| 360 |
INTENTIONAL DOSE OMISSION |
37 |
0.0013 |
| 361 |
ARTHRITIS INFECTIVE |
6 |
0.0013 |
| 362 |
MUSCULOSKELETAL CHEST PAIN |
20 |
0.0013 |
| 363 |
INFECTION |
187 |
0.0013 |
| 364 |
PHARYNGITIS |
16 |
0.0013 |
| 365 |
RIGHT VENTRICULAR FAILURE |
9 |
0.0013 |
| 366 |
ORAL HERPES |
25 |
0.0013 |
| 367 |
FOOT FRACTURE |
24 |
0.0013 |
| 368 |
PRODUCT DOSE OMISSION ISSUE |
372 |
0.0013 |
| 369 |
OSTEOPOROSIS |
52 |
0.0013 |
| 370 |
INTENTIONAL PRODUCT USE ISSUE |
110 |
0.0013 |
| 371 |
DYSURIA |
46 |
0.0012 |
| 372 |
HUMERUS FRACTURE |
6 |
0.0012 |
| 373 |
PRODUCT DISPENSING ERROR |
27 |
0.0012 |
| 374 |
HYPOACUSIS |
53 |
0.0012 |
| 375 |
VITAMIN D DEFICIENCY |
12 |
0.0012 |
| 376 |
POST PROCEDURAL INFECTION |
10 |
0.0012 |
| 377 |
ASPHYXIA |
10 |
0.0012 |
| 378 |
LUNG INFECTION |
19 |
0.0012 |
| 379 |
LIGAMENT SPRAIN |
12 |
0.0012 |
| 380 |
CORONAVIRUS INFECTION |
8 |
0.0012 |
| 381 |
SPINAL COMPRESSION FRACTURE |
10 |
0.0012 |
| 382 |
FALL |
401 |
0.0012 |
| 383 |
DEVICE USE ISSUE |
21 |
0.0012 |
| 384 |
BACK INJURY |
13 |
0.0012 |
| 385 |
DEVICE PHYSICAL PROPERTY ISSUE |
9 |
0.0012 |
| 386 |
CARDIAC FAILURE CHRONIC |
5 |
0.0012 |
| 387 |
GOUT |
21 |
0.0012 |
| 388 |
BACK DISORDER |
19 |
0.0012 |
| 389 |
ATRIOVENTRICULAR BLOCK |
9 |
0.0012 |
| 390 |
RESPIRATORY FAILURE |
84 |
0.0012 |
| 391 |
FIBROMYALGIA |
28 |
0.0012 |
| 392 |
EYE INFECTION |
13 |
0.0012 |
| 393 |
BONE CANCER |
5 |
0.0011 |
| 394 |
PRODUCT ADMINISTRATION ERROR |
23 |
0.0011 |
| 395 |
NEPHROLITHIASIS |
52 |
0.0011 |
| 396 |
CATHETERISATION CARDIAC |
5 |
0.0011 |
| 397 |
HEART RATE INCREASED |
111 |
0.0011 |
| 398 |
URINARY TRACT INFECTION |
191 |
0.0011 |
| 399 |
HIP FRACTURE |
36 |
0.0011 |
| 400 |
ORAL PAIN |
25 |
0.0011 |
| 401 |
PANIC REACTION |
8 |
0.0011 |
| 402 |
INABILITY TO AFFORD MEDICATION |
11 |
0.0011 |
| 403 |
HEAD INJURY |
35 |
0.0011 |
| 404 |
FOREIGN BODY SENSATION IN EYES |
7 |
0.0011 |
| 405 |
TRANSIENT ISCHAEMIC ATTACK |
37 |
0.0011 |
| 406 |
ASPIRATION |
12 |
0.0011 |
| 407 |
BLOOD IRON DECREASED |
13 |
0.0011 |
| 408 |
LOWER LIMB FRACTURE |
21 |
0.0011 |
| 409 |
ORAL DISORDER |
8 |
0.0011 |
| 410 |
PROSTATIC DISORDER |
6 |
0.0011 |
| 411 |
CHEST PAIN |
201 |
0.0011 |
| 412 |
HIATUS HERNIA |
14 |
0.0011 |
| 413 |
PRODUCT USE COMPLAINT |
17 |
0.0011 |
| 414 |
BACTERIAL INFECTION |
20 |
0.0011 |
| 415 |
CARDIAC DISORDER |
100 |
0.0011 |
| 416 |
ASPERGILLUS INFECTION |
7 |
0.0011 |
| 417 |
DEVICE ISSUE |
95 |
0.0011 |
| 418 |
FACIAL PARALYSIS |
9 |
0.0011 |
| 419 |
TROPONIN INCREASED |
8 |
0.0011 |
| 420 |
HYPONATRAEMIA |
59 |
0.0010 |
| 421 |
MUSCULOSKELETAL DISCOMFORT |
18 |
0.0010 |
| 422 |
IMPAIRED QUALITY OF LIFE |
15 |
0.0010 |
| 423 |
BREAST MASS |
7 |
0.0010 |
| 424 |
EYE PRURITUS |
35 |
0.0010 |
| 425 |
POST PROCEDURAL COMPLICATION |
20 |
0.0010 |
| 426 |
MOUTH SWELLING |
6 |
0.0010 |
| 427 |
THYROID DISORDER |
16 |
0.0010 |
| 428 |
PULMONARY ARTERIAL HYPERTENSION |
15 |
0.0010 |
| 429 |
ELECTROLYTE IMBALANCE |
12 |
0.0010 |
| 430 |
POST PROCEDURAL HAEMORRHAGE |
12 |
0.0010 |
| 431 |
EAR PAIN |
20 |
0.0010 |
| 432 |
IMPAIRED GASTRIC EMPTYING |
14 |
0.0010 |
| 433 |
PRODUCT COMPLAINT |
26 |
0.0010 |
| 434 |
DIABETES MELLITUS |
78 |
0.0010 |
| 435 |
IMMUNOSUPPRESSION |
9 |
0.0010 |
| 436 |
HEART RATE IRREGULAR |
23 |
0.0010 |
| 437 |
AFFECTIVE DISORDER |
8 |
0.0010 |
| 438 |
ARTHRITIS |
80 |
0.0010 |
| 439 |
PHARYNGITIS STREPTOCOCCAL |
11 |
0.0010 |
| 440 |
FURUNCLE |
8 |
0.0010 |
| 441 |
CARDIAC FAILURE CONGESTIVE |
81 |
0.0010 |
| 442 |
FACIAL PAIN |
9 |
0.0010 |
| 443 |
SLEEP DISORDER |
71 |
0.0010 |
| 444 |
NEOPLASM MALIGNANT |
67 |
0.0010 |
| 445 |
SYMPTOM RECURRENCE |
6 |
0.0010 |
| 446 |
ATRIAL FLUTTER |
8 |
0.0010 |
| 447 |
PLATELET COUNT INCREASED |
13 |
0.0010 |
| 448 |
TOOTHACHE |
18 |
0.0010 |
| 449 |
PRODUCT PHYSICAL ISSUE |
20 |
0.0010 |
| 450 |
PULMONARY OEDEMA |
44 |
0.0010 |
| 451 |
NEUTROPHIL COUNT INCREASED |
10 |
0.0010 |
| 452 |
MIGRAINE |
93 |
0.0010 |
| 453 |
CACHEXIA |
5 |
0.0010 |
| 454 |
CARDIAC FAILURE |
78 |
0.0010 |
| 455 |
BENIGN PROSTATIC HYPERPLASIA |
5 |
0.0010 |
| 456 |
THROAT TIGHTNESS |
26 |
0.0010 |
| 457 |
DISABILITY |
19 |
0.0010 |
| 458 |
INTERVERTEBRAL DISC PROTRUSION |
21 |
0.0010 |
| 459 |
PRODUCT TASTE ABNORMAL |
13 |
0.0010 |
| 460 |
FUNGAL INFECTION |
32 |
0.0010 |
| 461 |
INTENTIONAL UNDERDOSE |
7 |
0.0010 |
| 462 |
NEOPLASM |
11 |
0.0010 |
| 463 |
PHOTOPSIA |
6 |
0.0009 |
| 464 |
ARTHROPOD BITE |
7 |
0.0009 |
| 465 |
MALAISE |
412 |
0.0009 |
| 466 |
HOSPITALISATION |
144 |
0.0009 |
| 467 |
BODY HEIGHT DECREASED |
10 |
0.0009 |
| 468 |
ROTATOR CUFF SYNDROME |
12 |
0.0009 |
| 469 |
POOR QUALITY SLEEP |
20 |
0.0009 |
| 470 |
INTESTINAL OBSTRUCTION |
35 |
0.0009 |
| 471 |
DEVICE DEFECTIVE |
16 |
0.0009 |
| 472 |
DEVICE FAILURE |
14 |
0.0009 |
| 473 |
WOUND INFECTION |
10 |
0.0009 |
| 474 |
HOSPICE CARE |
9 |
0.0009 |
| 475 |
SPINAL OSTEOARTHRITIS |
8 |
0.0009 |
| 476 |
LYMPHADENOPATHY |
32 |
0.0009 |
| 477 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
10 |
0.0009 |
| 478 |
PERIPHERAL SWELLING |
139 |
0.0009 |
| 479 |
HYPERTENSIVE CRISIS |
10 |
0.0009 |
| 480 |
POST-TRAUMATIC STRESS DISORDER |
6 |
0.0009 |
| 481 |
DEMENTIA |
25 |
0.0009 |
| 482 |
CARDIOMEGALY |
11 |
0.0009 |
| 483 |
SMALL INTESTINAL OBSTRUCTION |
11 |
0.0009 |
| 484 |
PLEURAL EFFUSION |
54 |
0.0009 |
| 485 |
PRODUCT LABEL ISSUE |
6 |
0.0009 |
| 486 |
TOOTH ABSCESS |
9 |
0.0009 |
| 487 |
BLOOD PRESSURE INCREASED |
135 |
0.0009 |
| 488 |
DRUG EFFECT INCOMPLETE |
32 |
0.0009 |
| 489 |
DEAFNESS |
23 |
0.0009 |
| 490 |
DRUG EFFECT LESS THAN EXPECTED |
13 |
0.0009 |
| 491 |
INFARCTION |
6 |
0.0009 |
| 492 |
GASTRITIS |
23 |
0.0009 |
| 493 |
UROSEPSIS |
8 |
0.0009 |
| 494 |
EYE DISCHARGE |
9 |
0.0009 |
| 495 |
WEIGHT FLUCTUATION |
9 |
0.0009 |
| 496 |
EXTRASYSTOLES |
6 |
0.0009 |
| 497 |
VISION BLURRED |
118 |
0.0009 |
| 498 |
HYPERKALAEMIA |
30 |
0.0009 |
| 499 |
JOINT DISLOCATION |
9 |
0.0009 |
| 500 |
BLINDNESS UNILATERAL |
12 |
0.0008 |
| 501 |
ANAPHYLACTIC REACTION |
47 |
0.0008 |
| 502 |
RENAL PAIN |
9 |
0.0008 |
| 503 |
LEUKAEMIA |
8 |
0.0008 |
| 504 |
DIVERTICULUM |
6 |
0.0008 |
| 505 |
BACTERAEMIA |
10 |
0.0008 |
| 506 |
PRODUCT PACKAGING ISSUE |
8 |
0.0008 |
| 507 |
ANKLE FRACTURE |
13 |
0.0008 |
| 508 |
GAIT INABILITY |
28 |
0.0008 |
| 509 |
BEDRIDDEN |
11 |
0.0008 |
| 510 |
HERPES ZOSTER |
48 |
0.0008 |
| 511 |
WEIGHT DECREASED |
232 |
0.0008 |
| 512 |
TONGUE DISORDER |
6 |
0.0008 |
| 513 |
EPISTAXIS |
62 |
0.0008 |
| 514 |
LOCALISED INFECTION |
20 |
0.0008 |
| 515 |
NOCTURIA |
10 |
0.0008 |
| 516 |
OFF LABEL USE |
716 |
0.0008 |
| 517 |
PRODUCT CONTAINER ISSUE |
7 |
0.0008 |
| 518 |
TOOTH FRACTURE |
9 |
0.0008 |
| 519 |
CARDIAC OPERATION |
7 |
0.0008 |
| 520 |
HEPATOMEGALY |
8 |
0.0008 |
| 521 |
GLOMERULAR FILTRATION RATE DECREASED |
10 |
0.0008 |
| 522 |
DEPRESSED MOOD |
43 |
0.0008 |
| 523 |
BLOOD PRESSURE DIASTOLIC DECREASED |
6 |
0.0008 |
| 524 |
SPINAL OPERATION |
10 |
0.0008 |
| 525 |
THROMBOSIS |
65 |
0.0008 |
| 526 |
SKIN SWELLING |
7 |
0.0008 |
| 527 |
ASTHENIA |
302 |
0.0008 |
| 528 |
ARRHYTHMIA |
38 |
0.0008 |
| 529 |
HYPERSOMNIA |
23 |
0.0008 |
| 530 |
INTESTINAL PERFORATION |
9 |
0.0008 |
| 531 |
OCULAR DISCOMFORT |
9 |
0.0008 |
| 532 |
BLOOD CALCIUM INCREASED |
7 |
0.0008 |
| 533 |
RESPIRATORY ARREST |
22 |
0.0008 |
| 534 |
HEART RATE DECREASED |
28 |
0.0008 |
| 535 |
CHROMATURIA |
18 |
0.0008 |
| 536 |
HYPOAESTHESIA ORAL |
12 |
0.0008 |
| 537 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
7 |
0.0008 |
| 538 |
SKIN CANCER |
17 |
0.0008 |
| 539 |
SYNCOPE |
79 |
0.0008 |
| 540 |
SCAB |
9 |
0.0008 |
| 541 |
TASTE DISORDER |
16 |
0.0008 |
| 542 |
INTERNAL HAEMORRHAGE |
9 |
0.0008 |
| 543 |
THERAPEUTIC RESPONSE SHORTENED |
26 |
0.0008 |
| 544 |
EYE SWELLING |
29 |
0.0008 |
| 545 |
URINARY RETENTION |
26 |
0.0008 |
| 546 |
LYMPHOMA |
12 |
0.0008 |
| 547 |
URINARY INCONTINENCE |
23 |
0.0008 |
| 548 |
CARDIAC FLUTTER |
5 |
0.0008 |
| 549 |
RENAL DISORDER |
36 |
0.0008 |
| 550 |
PRODUCT USE ISSUE |
145 |
0.0008 |
| 551 |
SEPSIS |
86 |
0.0008 |
| 552 |
BACK PAIN |
179 |
0.0008 |
| 553 |
HYPERTENSION |
163 |
0.0008 |
| 554 |
TENDERNESS |
8 |
0.0008 |
| 555 |
HEMIPARESIS |
13 |
0.0008 |
| 556 |
POLLAKIURIA |
32 |
0.0008 |
| 557 |
EXOSTOSIS |
7 |
0.0008 |
| 558 |
SPEECH DISORDER |
40 |
0.0008 |
| 559 |
BRAIN NEOPLASM |
7 |
0.0008 |
| 560 |
LACRIMATION INCREASED |
23 |
0.0008 |
| 561 |
INJECTION SITE DISCOMFORT |
8 |
0.0008 |
| 562 |
PNEUMONIA ASPIRATION |
19 |
0.0008 |
| 563 |
NERVE COMPRESSION |
7 |
0.0008 |
| 564 |
DIZZINESS |
378 |
0.0008 |
| 565 |
ACCIDENT |
9 |
0.0008 |
| 566 |
HEPATIC STEATOSIS |
14 |
0.0008 |
| 567 |
HEADACHE |
469 |
0.0007 |
| 568 |
PHOTOPHOBIA |
14 |
0.0007 |
| 569 |
PALPITATIONS |
87 |
0.0007 |
| 570 |
PAIN IN JAW |
21 |
0.0007 |
| 571 |
COLON CANCER |
11 |
0.0007 |
| 572 |
SHOCK HAEMORRHAGIC |
6 |
0.0007 |
| 573 |
BIPOLAR DISORDER |
8 |
0.0007 |
| 574 |
PERICARDIAL EFFUSION |
17 |
0.0007 |
| 575 |
FEELING JITTERY |
14 |
0.0007 |
| 576 |
CEREBROVASCULAR ACCIDENT |
124 |
0.0007 |
| 577 |
OEDEMA PERIPHERAL |
89 |
0.0007 |
| 578 |
ESCHERICHIA INFECTION |
6 |
0.0007 |
| 579 |
GALLBLADDER DISORDER |
13 |
0.0007 |
| 580 |
EYE PAIN |
41 |
0.0007 |
| 581 |
DRY EYE |
36 |
0.0007 |
| 582 |
LIP SWELLING |
24 |
0.0007 |
| 583 |
TOOTH DISORDER |
16 |
0.0007 |
| 584 |
INFLAMMATION |
37 |
0.0007 |
| 585 |
KNEE ARTHROPLASTY |
15 |
0.0007 |
| 586 |
SENSATION OF FOREIGN BODY |
6 |
0.0007 |
| 587 |
PRODUCT DOSE OMISSION IN ERROR |
20 |
0.0007 |
| 588 |
DISCOMFORT |
43 |
0.0007 |
| 589 |
INTRAOCULAR PRESSURE INCREASED |
9 |
0.0007 |
| 590 |
VITAMIN D DECREASED |
6 |
0.0007 |
| 591 |
MICTURITION URGENCY |
8 |
0.0007 |
| 592 |
PYREXIA |
242 |
0.0007 |
| 593 |
CONTUSION |
67 |
0.0007 |
| 594 |
PULMONARY EMBOLISM |
66 |
0.0007 |
| 595 |
VISUAL IMPAIRMENT |
86 |
0.0007 |
| 596 |
HYPOKALAEMIA |
32 |
0.0007 |
| 597 |
SCIATICA |
11 |
0.0007 |
| 598 |
BLOOD SODIUM DECREASED |
13 |
0.0007 |
| 599 |
ORTHOSTATIC HYPOTENSION |
12 |
0.0007 |
| 600 |
FEELING ABNORMAL |
165 |
0.0007 |
| 601 |
PRODUCT USE IN UNAPPROVED INDICATION |
170 |
0.0007 |
| 602 |
DIVERTICULITIS |
19 |
0.0007 |
| 603 |
INJECTION SITE RASH |
21 |
0.0007 |
| 604 |
ARTHROPATHY |
38 |
0.0007 |
| 605 |
RESPIRATORY RATE INCREASED |
6 |
0.0007 |
| 606 |
INTENTIONAL PRODUCT MISUSE |
59 |
0.0007 |
| 607 |
THERAPY INTERRUPTED |
48 |
0.0007 |
| 608 |
LOSS OF CONSCIOUSNESS |
86 |
0.0007 |
| 609 |
CEREBRAL HAEMORRHAGE |
24 |
0.0007 |
| 610 |
RASH ERYTHEMATOUS |
32 |
0.0007 |
| 611 |
THERAPEUTIC RESPONSE UNEXPECTED |
30 |
0.0007 |
| 612 |
THERAPY NON-RESPONDER |
30 |
0.0007 |
| 613 |
INCONTINENCE |
7 |
0.0007 |
| 614 |
CONDITION AGGRAVATED |
200 |
0.0007 |
| 615 |
DEVICE MECHANICAL ISSUE |
9 |
0.0007 |
| 616 |
CELLULITIS |
33 |
0.0007 |
| 617 |
RETINAL DETACHMENT |
6 |
0.0007 |
| 618 |
FATIGUE |
508 |
0.0007 |
| 619 |
INCREASED TENDENCY TO BRUISE |
6 |
0.0007 |
| 620 |
NIGHT SWEATS |
21 |
0.0007 |
| 621 |
NERVOUSNESS |
34 |
0.0007 |
| 622 |
TREMOR |
108 |
0.0007 |
| 623 |
DYSPEPSIA |
64 |
0.0006 |
| 624 |
PHARYNGEAL OEDEMA |
10 |
0.0006 |
| 625 |
PROCEDURAL PAIN |
18 |
0.0006 |
| 626 |
FEELING COLD |
18 |
0.0006 |
| 627 |
LIMB DISCOMFORT |
20 |
0.0006 |
| 628 |
TENDONITIS |
10 |
0.0006 |
| 629 |
CARPAL TUNNEL SYNDROME |
9 |
0.0006 |
| 630 |
SWELLING |
60 |
0.0006 |
| 631 |
OESOPHAGITIS |
7 |
0.0006 |
| 632 |
SWOLLEN TONGUE |
20 |
0.0006 |
| 633 |
CHILLS |
75 |
0.0006 |
| 634 |
ARTERIOSCLEROSIS |
6 |
0.0006 |
| 635 |
ARTERIAL OCCLUSIVE DISEASE |
5 |
0.0006 |
| 636 |
NERVE INJURY |
7 |
0.0006 |
| 637 |
LETHARGY |
36 |
0.0006 |
| 638 |
SKIN INFECTION |
7 |
0.0006 |
| 639 |
PARAESTHESIA ORAL |
9 |
0.0006 |
| 640 |
ANXIETY |
177 |
0.0006 |
| 641 |
PRESCRIBED OVERDOSE |
12 |
0.0006 |
| 642 |
HYPOKINESIA |
9 |
0.0006 |
| 643 |
HYPERSENSITIVITY |
115 |
0.0006 |
| 644 |
TACHYCARDIA |
55 |
0.0006 |
| 645 |
DIZZINESS POSTURAL |
6 |
0.0006 |
| 646 |
BLOOD PRESSURE DECREASED |
41 |
0.0006 |
| 647 |
DIPLOPIA |
16 |
0.0006 |
| 648 |
AUTOIMMUNE DISORDER |
6 |
0.0006 |
| 649 |
SKIN FISSURES |
12 |
0.0006 |
| 650 |
ECZEMA |
32 |
0.0006 |
| 651 |
DRUG INTOLERANCE |
59 |
0.0006 |
| 652 |
VITREOUS FLOATERS |
6 |
0.0006 |
| 653 |
IMMUNODEFICIENCY |
9 |
0.0006 |
| 654 |
ACUTE CORONARY SYNDROME |
5 |
0.0006 |
| 655 |
BONE DISORDER |
11 |
0.0006 |
| 656 |
HYPOTENSION |
121 |
0.0006 |
| 657 |
WEIGHT INCREASED |
134 |
0.0006 |
| 658 |
ATRIAL SEPTAL DEFECT |
5 |
0.0006 |
| 659 |
OSTEOPENIA |
9 |
0.0006 |
| 660 |
FACE OEDEMA |
10 |
0.0006 |
| 661 |
NECK PAIN |
33 |
0.0006 |
| 662 |
MYOCARDIAL INFARCTION |
103 |
0.0006 |
| 663 |
OCULAR HYPERAEMIA |
28 |
0.0006 |
| 664 |
MOTOR DYSFUNCTION |
6 |
0.0006 |
| 665 |
BODY TEMPERATURE INCREASED |
12 |
0.0006 |
| 666 |
ANGIOEDEMA |
26 |
0.0006 |
| 667 |
TINNITUS |
27 |
0.0006 |
| 668 |
HIP ARTHROPLASTY |
9 |
0.0006 |
| 669 |
GAIT DISTURBANCE |
112 |
0.0006 |
| 670 |
DRUG INEFFECTIVE |
771 |
0.0006 |
| 671 |
INITIAL INSOMNIA |
6 |
0.0006 |
| 672 |
DEVICE RELATED INFECTION |
9 |
0.0006 |
| 673 |
PRODUCT PREPARATION ERROR |
12 |
0.0006 |
| 674 |
CORONARY ARTERY OCCLUSION |
8 |
0.0006 |
| 675 |
BLOOD PRESSURE FLUCTUATION |
14 |
0.0006 |
| 676 |
MEMORY IMPAIRMENT |
80 |
0.0006 |
| 677 |
ACUTE MYOCARDIAL INFARCTION |
17 |
0.0006 |
| 678 |
INSOMNIA |
153 |
0.0006 |
| 679 |
ROAD TRAFFIC ACCIDENT |
24 |
0.0006 |
| 680 |
URTICARIA |
96 |
0.0006 |
| 681 |
OEDEMA |
31 |
0.0006 |
| 682 |
FEELING HOT |
35 |
0.0006 |
| 683 |
DEHYDRATION |
76 |
0.0006 |
| 684 |
SKIN DISORDER |
19 |
0.0006 |
| 685 |
SCRATCH |
6 |
0.0006 |
| 686 |
DEVICE OCCLUSION |
8 |
0.0006 |
| 687 |
COLD SWEAT |
10 |
0.0006 |
| 688 |
TENDON RUPTURE |
7 |
0.0006 |
| 689 |
OSTEOARTHRITIS |
24 |
0.0006 |
| 690 |
CLOSTRIDIUM DIFFICILE COLITIS |
6 |
0.0006 |
| 691 |
BLOOD POTASSIUM DECREASED |
17 |
0.0006 |
| 692 |
HEAD DISCOMFORT |
10 |
0.0006 |
| 693 |
CYST |
7 |
0.0006 |
| 694 |
DIALYSIS |
8 |
0.0006 |
| 695 |
HYPOTHYROIDISM |
18 |
0.0006 |
| 696 |
METABOLIC ACIDOSIS |
18 |
0.0006 |
| 697 |
SURGERY |
33 |
0.0006 |
| 698 |
INFUSION RELATED REACTION |
37 |
0.0006 |
| 699 |
VERTIGO |
34 |
0.0006 |
| 700 |
BLOOD CHOLESTEROL INCREASED |
26 |
0.0006 |
| 701 |
CARDIOGENIC SHOCK |
8 |
0.0006 |
| 702 |
INJURY |
39 |
0.0006 |
| 703 |
ABDOMINAL PAIN UPPER |
114 |
0.0006 |
| 704 |
PRESCRIBED UNDERDOSE |
11 |
0.0006 |
| 705 |
PRODUCT PRESCRIBING ISSUE |
12 |
0.0006 |
| 706 |
FEMUR FRACTURE |
17 |
0.0005 |
| 707 |
PANIC ATTACK |
20 |
0.0005 |
| 708 |
SKIN LESION |
15 |
0.0005 |
| 709 |
DENTAL CARIES |
6 |
0.0005 |
| 710 |
MEDICATION ERROR |
30 |
0.0005 |
| 711 |
AMNESIA |
35 |
0.0005 |
| 712 |
BLOOD UREA INCREASED |
9 |
0.0005 |
| 713 |
MALNUTRITION |
6 |
0.0005 |
| 714 |
PAIN IN EXTREMITY |
157 |
0.0005 |
| 715 |
ABDOMINAL PAIN |
123 |
0.0005 |
| 716 |
BLOOD URINE PRESENT |
10 |
0.0005 |
| 717 |
ILL-DEFINED DISORDER |
32 |
0.0005 |
| 718 |
GASTRIC ULCER |
10 |
0.0005 |
| 719 |
ACCIDENTAL EXPOSURE TO PRODUCT |
54 |
0.0005 |
| 720 |
RENAL IMPAIRMENT |
44 |
0.0005 |
| 721 |
ARTHRALGIA |
216 |
0.0005 |
| 722 |
MUSCULAR WEAKNESS |
59 |
0.0005 |
| 723 |
GENERAL PHYSICAL HEALTH DETERIORATION |
60 |
0.0005 |
| 724 |
DEVICE USE ERROR |
18 |
0.0005 |
| 725 |
PRURITUS |
199 |
0.0005 |
| 726 |
STAPHYLOCOCCAL INFECTION |
17 |
0.0005 |
| 727 |
NEEDLE ISSUE |
15 |
0.0005 |
| 728 |
VASCULITIS |
6 |
0.0005 |
| 729 |
RASH MACULAR |
18 |
0.0005 |
| 730 |
PALLOR |
14 |
0.0005 |
| 731 |
PAIN |
316 |
0.0005 |
| 732 |
ABDOMINAL PAIN LOWER |
13 |
0.0005 |
| 733 |
BURNING SENSATION |
36 |
0.0005 |
| 734 |
TYPE 2 DIABETES MELLITUS |
17 |
0.0005 |
| 735 |
DISEASE RECURRENCE |
24 |
0.0005 |
| 736 |
HAEMATOCRIT DECREASED |
10 |
0.0005 |
| 737 |
RHABDOMYOLYSIS |
21 |
0.0005 |
| 738 |
GASTROINTESTINAL HAEMORRHAGE |
42 |
0.0005 |
| 739 |
COLITIS |
19 |
0.0005 |
| 740 |
DYSGEUSIA |
37 |
0.0005 |
| 741 |
WHITE BLOOD CELL COUNT INCREASED |
19 |
0.0005 |
| 742 |
CONSTIPATION |
108 |
0.0005 |
| 743 |
RESTLESS LEGS SYNDROME |
9 |
0.0005 |
| 744 |
FLATULENCE |
28 |
0.0005 |
| 745 |
PRESYNCOPE |
12 |
0.0005 |
| 746 |
DEATH |
425 |
0.0005 |
| 747 |
GASTROINTESTINAL DISORDER |
44 |
0.0005 |
| 748 |
INJECTION SITE URTICARIA |
12 |
0.0005 |
| 749 |
SUBDURAL HAEMATOMA |
7 |
0.0005 |
| 750 |
IMPAIRED HEALING |
16 |
0.0005 |
| 751 |
CHRONIC KIDNEY DISEASE |
37 |
0.0005 |
| 752 |
SOMNOLENCE |
98 |
0.0005 |
| 753 |
EYE IRRITATION |
28 |
0.0005 |
| 754 |
ANOSMIA |
7 |
0.0005 |
| 755 |
HYPERTHYROIDISM |
7 |
0.0005 |
| 756 |
GENERALISED TONIC-CLONIC SEIZURE |
8 |
0.0005 |
| 757 |
PRODUCT AVAILABILITY ISSUE |
11 |
0.0005 |
| 758 |
THINKING ABNORMAL |
9 |
0.0005 |
| 759 |
ILEUS |
6 |
0.0005 |
| 760 |
COMPLICATION ASSOCIATED WITH DEVICE |
7 |
0.0005 |
| 761 |
AGEUSIA |
12 |
0.0005 |
| 762 |
RASH PRURITIC |
26 |
0.0005 |
| 763 |
STOMATITIS |
29 |
0.0005 |
| 764 |
MYALGIA |
81 |
0.0005 |
| 765 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
8 |
0.0005 |
| 766 |
FRACTURE |
9 |
0.0005 |
| 767 |
DERMATITIS ATOPIC |
25 |
0.0005 |
| 768 |
LIVER DISORDER |
21 |
0.0005 |
| 769 |
HYPERHIDROSIS |
61 |
0.0005 |
| 770 |
MOBILITY DECREASED |
34 |
0.0005 |
| 771 |
RASH |
206 |
0.0005 |
| 772 |
EATING DISORDER |
10 |
0.0005 |
| 773 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
95 |
0.0005 |
| 774 |
MUSCLE SPASMS |
86 |
0.0005 |
| 775 |
IRRITABLE BOWEL SYNDROME |
10 |
0.0005 |
| 776 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
6 |
0.0005 |
| 777 |
ABDOMINAL DISCOMFORT |
78 |
0.0005 |
| 778 |
SKIN ULCER |
12 |
0.0005 |
| 779 |
AGITATION |
34 |
0.0005 |
| 780 |
PRURITUS GENERALISED |
10 |
0.0005 |
| 781 |
HAEMORRHOIDS |
9 |
0.0005 |
| 782 |
HYPOAESTHESIA |
69 |
0.0005 |
| 783 |
NODULE |
6 |
0.0005 |
| 784 |
MENTAL DISORDER |
20 |
0.0005 |
| 785 |
VOMITING |
216 |
0.0005 |
| 786 |
DECREASED APPETITE |
106 |
0.0005 |
| 787 |
JOINT SWELLING |
55 |
0.0005 |
| 788 |
IMMUNE SYSTEM DISORDER |
6 |
0.0005 |
| 789 |
NEURALGIA |
11 |
0.0005 |
| 790 |
DYSARTHRIA |
17 |
0.0005 |
| 791 |
INJECTION SITE ERYTHEMA |
56 |
0.0005 |
| 792 |
INJECTION SITE BRUISING |
36 |
0.0005 |
| 793 |
BALANCE DISORDER |
39 |
0.0005 |
| 794 |
ABDOMINAL DISTENSION |
47 |
0.0004 |
| 795 |
EYE HAEMORRHAGE |
6 |
0.0004 |
| 796 |
INFLUENZA LIKE ILLNESS |
37 |
0.0004 |
| 797 |
THERAPY PARTIAL RESPONDER |
7 |
0.0004 |
| 798 |
INJECTION SITE PRURITUS |
30 |
0.0004 |
| 799 |
THIRST |
8 |
0.0004 |
| 800 |
ANAEMIA |
85 |
0.0004 |
| 801 |
INJECTION SITE SWELLING |
34 |
0.0004 |
| 802 |
OSTEOMYELITIS |
8 |
0.0004 |
| 803 |
HALLUCINATION, AUDITORY |
7 |
0.0004 |
| 804 |
HAEMORRHAGE |
46 |
0.0004 |
| 805 |
PREMATURE DELIVERY |
7 |
0.0004 |
| 806 |
TREATMENT NONCOMPLIANCE |
24 |
0.0004 |
| 807 |
ACUTE KIDNEY INJURY |
67 |
0.0004 |
| 808 |
INTENTIONAL OVERDOSE |
28 |
0.0004 |
| 809 |
DIARRHOEA |
281 |
0.0004 |
| 810 |
HAEMATEMESIS |
11 |
0.0004 |
| 811 |
BRADYCARDIA |
23 |
0.0004 |
| 812 |
INJECTION SITE MASS |
16 |
0.0004 |
| 813 |
MUSCLE TIGHTNESS |
7 |
0.0004 |
| 814 |
DYSPHAGIA |
41 |
0.0004 |
| 815 |
DEPRESSION |
98 |
0.0004 |
| 816 |
SWELLING FACE |
28 |
0.0004 |
| 817 |
NAUSEA |
340 |
0.0004 |
| 818 |
DERMATITIS |
9 |
0.0004 |
| 819 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
20 |
0.0004 |
| 820 |
INJECTION SITE PAIN |
131 |
0.0004 |
| 821 |
HAEMATOMA |
11 |
0.0004 |
| 822 |
RENAL FAILURE |
56 |
0.0004 |
| 823 |
CONFUSIONAL STATE |
68 |
0.0004 |
| 824 |
ERUCTATION |
8 |
0.0004 |
| 825 |
CLOSTRIDIUM DIFFICILE INFECTION |
9 |
0.0004 |
| 826 |
CARDIAC ARREST |
34 |
0.0004 |
| 827 |
GASTROENTERITIS |
6 |
0.0004 |
| 828 |
SCAR |
7 |
0.0004 |
| 829 |
HAEMATURIA |
14 |
0.0004 |
| 830 |
COGNITIVE DISORDER |
19 |
0.0004 |
| 831 |
MOVEMENT DISORDER |
13 |
0.0004 |
| 832 |
SKIN HAEMORRHAGE |
6 |
0.0004 |
| 833 |
GLOSSODYNIA |
9 |
0.0004 |
| 834 |
MUSCULOSKELETAL PAIN |
21 |
0.0004 |
| 835 |
HAEMATOCHEZIA |
22 |
0.0004 |
| 836 |
PRODUCT DOSE OMISSION |
26 |
0.0004 |
| 837 |
BLOOD CREATININE INCREASED |
26 |
0.0004 |
| 838 |
THERAPEUTIC RESPONSE DECREASED |
24 |
0.0004 |
| 839 |
FEEDING DISORDER |
8 |
0.0004 |
| 840 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
14 |
0.0004 |
| 841 |
BONE PAIN |
23 |
0.0004 |
| 842 |
DRUG DISPENSING ERROR |
6 |
0.0004 |
| 843 |
INTERSTITIAL LUNG DISEASE |
19 |
0.0004 |
| 844 |
SKIN DISCOLOURATION |
18 |
0.0004 |
| 845 |
HALLUCINATION |
29 |
0.0004 |
| 846 |
BASAL CELL CARCINOMA |
6 |
0.0004 |
| 847 |
ACCIDENTAL OVERDOSE |
14 |
0.0004 |
| 848 |
MATERNAL EXPOSURE DURING PREGNANCY |
34 |
0.0004 |
| 849 |
ULCER |
6 |
0.0004 |
| 850 |
DELIRIUM |
13 |
0.0004 |
| 851 |
SKIN IRRITATION |
17 |
0.0004 |
| 852 |
UNEVALUABLE EVENT |
28 |
0.0004 |
| 853 |
ERYTHEMA |
76 |
0.0004 |
| 854 |
BLOOD POTASSIUM INCREASED |
6 |
0.0004 |
| 855 |
SEPTIC SHOCK |
16 |
0.0004 |
| 856 |
INCREASED APPETITE |
7 |
0.0004 |
| 857 |
CHOLELITHIASIS |
12 |
0.0004 |
| 858 |
APHASIA |
11 |
0.0004 |
| 859 |
HAEMOGLOBIN DECREASED |
37 |
0.0004 |
| 860 |
MENTAL STATUS CHANGES |
10 |
0.0004 |
| 861 |
WOUND |
10 |
0.0004 |
| 862 |
FOETAL EXPOSURE DURING PREGNANCY |
29 |
0.0004 |
| 863 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
12 |
0.0004 |
| 864 |
CIRCULATORY COLLAPSE |
6 |
0.0004 |
| 865 |
HYPOPHAGIA |
9 |
0.0004 |
| 866 |
INTERNATIONAL NORMALISED RATIO INCREASED |
10 |
0.0004 |
| 867 |
ANAPHYLACTIC SHOCK |
9 |
0.0003 |
| 868 |
HOT FLUSH |
26 |
0.0003 |
| 869 |
BLINDNESS |
14 |
0.0003 |
| 870 |
RHEUMATOID ARTHRITIS |
39 |
0.0003 |
| 871 |
ANHEDONIA |
9 |
0.0003 |
| 872 |
DYSSTASIA |
10 |
0.0003 |
| 873 |
INCORRECT DOSE ADMINISTERED |
78 |
0.0003 |
| 874 |
CARDIOMYOPATHY |
5 |
0.0003 |
| 875 |
NEUROPATHY PERIPHERAL |
32 |
0.0003 |
| 876 |
HEPATIC CANCER |
8 |
0.0003 |
| 877 |
PREMATURE BABY |
10 |
0.0003 |
| 878 |
MOUTH ULCERATION |
7 |
0.0003 |
| 879 |
THERAPY CESSATION |
17 |
0.0003 |
| 880 |
MENTAL IMPAIRMENT |
8 |
0.0003 |
| 881 |
DISORIENTATION |
13 |
0.0003 |
| 882 |
RECTAL HAEMORRHAGE |
14 |
0.0003 |
| 883 |
BLISTER |
18 |
0.0003 |
| 884 |
HEPATIC CIRRHOSIS |
6 |
0.0003 |
| 885 |
CYANOSIS |
5 |
0.0003 |
| 886 |
NIGHTMARE |
11 |
0.0003 |
| 887 |
OVERDOSE |
68 |
0.0003 |
| 888 |
COMA |
15 |
0.0003 |
| 889 |
RASH PAPULAR |
7 |
0.0003 |
| 890 |
DRUG PRESCRIBING ERROR |
6 |
0.0003 |
| 891 |
BLOOD PRESSURE SYSTOLIC INCREASED |
6 |
0.0003 |
| 892 |
EXPOSURE DURING PREGNANCY |
19 |
0.0003 |
| 893 |
INJECTION SITE REACTION |
21 |
0.0003 |
| 894 |
FLUSHING |
31 |
0.0003 |
| 895 |
PSYCHOTIC DISORDER |
9 |
0.0003 |
| 896 |
PANCYTOPENIA |
17 |
0.0003 |
| 897 |
EXPIRED PRODUCT ADMINISTERED |
10 |
0.0003 |
| 898 |
PARAESTHESIA |
47 |
0.0003 |
| 899 |
FEAR |
8 |
0.0003 |
| 900 |
CORONARY ARTERY DISEASE |
9 |
0.0003 |
| 901 |
DISTURBANCE IN ATTENTION |
16 |
0.0003 |
| 902 |
MOOD ALTERED |
8 |
0.0003 |
| 903 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
13 |
0.0003 |
| 904 |
CARDIO-RESPIRATORY ARREST |
12 |
0.0003 |
| 905 |
SKIN EXFOLIATION |
24 |
0.0003 |
| 906 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
8 |
0.0003 |
| 907 |
SEIZURE |
32 |
0.0003 |
| 908 |
PANCREATIC CARCINOMA |
8 |
0.0003 |
| 909 |
ALTERED STATE OF CONSCIOUSNESS |
6 |
0.0003 |
| 910 |
GASTRIC CANCER |
7 |
0.0003 |
| 911 |
HYPERGLYCAEMIA |
10 |
0.0003 |
| 912 |
MUSCULOSKELETAL STIFFNESS |
24 |
0.0003 |
| 913 |
UNRESPONSIVE TO STIMULI |
7 |
0.0003 |
| 914 |
LABORATORY TEST ABNORMAL |
8 |
0.0003 |
| 915 |
BLOOD GLUCOSE ABNORMAL |
5 |
0.0003 |
| 916 |
DRY SKIN |
36 |
0.0003 |
| 917 |
ADVERSE DRUG REACTION |
24 |
0.0003 |
| 918 |
JOINT STIFFNESS |
7 |
0.0003 |
| 919 |
GASTRIC DISORDER |
9 |
0.0003 |
| 920 |
BREAST CANCER FEMALE |
7 |
0.0003 |
| 921 |
DEEP VEIN THROMBOSIS |
17 |
0.0003 |
| 922 |
SHOCK |
6 |
0.0003 |
| 923 |
MUSCLE TWITCHING |
6 |
0.0003 |
| 924 |
PAIN OF SKIN |
7 |
0.0003 |
| 925 |
BREAST CANCER |
24 |
0.0003 |
| 926 |
DEVICE DIFFICULT TO USE |
17 |
0.0003 |
| 927 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
10 |
0.0003 |
| 928 |
BLOOD GLUCOSE DECREASED |
12 |
0.0002 |
| 929 |
HEPATIC ENZYME INCREASED |
17 |
0.0002 |
| 930 |
DRUG INTERACTION |
39 |
0.0002 |
| 931 |
LIVER INJURY |
6 |
0.0002 |
| 932 |
ASCITES |
7 |
0.0002 |
| 933 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
6 |
0.0002 |
| 934 |
ALOPECIA |
46 |
0.0002 |
| 935 |
RASH GENERALISED |
6 |
0.0002 |
| 936 |
EMOTIONAL DISORDER |
7 |
0.0002 |
| 937 |
PANCREATITIS |
12 |
0.0002 |
| 938 |
PROSTATE CANCER |
18 |
0.0002 |
| 939 |
FREQUENT BOWEL MOVEMENTS |
6 |
0.0002 |
| 940 |
AGGRESSION |
11 |
0.0002 |
| 941 |
UNDERDOSE |
16 |
0.0002 |
| 942 |
SUICIDAL IDEATION |
20 |
0.0002 |
| 943 |
VISUAL ACUITY REDUCED |
7 |
0.0002 |
| 944 |
PRODUCT SUBSTITUTION ISSUE |
12 |
0.0002 |
| 945 |
ANGER |
7 |
0.0002 |
| 946 |
HYPOGLYCAEMIA |
10 |
0.0002 |
| 947 |
RENAL INJURY |
6 |
0.0002 |
| 948 |
PSORIASIS |
26 |
0.0002 |
| 949 |
CONTRAINDICATED PRODUCT ADMINISTERED |
6 |
0.0002 |
| 950 |
DEVICE BREAKAGE |
8 |
0.0002 |
| 951 |
BLOOD GLUCOSE INCREASED |
37 |
0.0002 |
| 952 |
CRYING |
7 |
0.0002 |
| 953 |
C-REACTIVE PROTEIN INCREASED |
7 |
0.0002 |
| 954 |
NERVOUS SYSTEM DISORDER |
6 |
0.0002 |
| 955 |
WHITE BLOOD CELL COUNT DECREASED |
20 |
0.0002 |
| 956 |
DEVICE LEAKAGE |
8 |
0.0002 |
| 957 |
OSTEONECROSIS |
6 |
0.0002 |
| 958 |
PLASMA CELL MYELOMA |
7 |
0.0002 |
| 959 |
BLADDER CANCER |
10 |
0.0002 |
| 960 |
RENAL CANCER |
8 |
0.0002 |
| 961 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
6 |
0.0002 |
| 962 |
MULTIPLE SCLEROSIS |
8 |
0.0002 |
| 963 |
NO ADVERSE EVENT |
30 |
0.0002 |
| 964 |
NEUTROPENIA |
22 |
0.0002 |
| 965 |
MULTIPLE SCLEROSIS RELAPSE |
11 |
0.0002 |
| 966 |
COLITIS ULCERATIVE |
7 |
0.0002 |
| 967 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
11 |
0.0002 |
| 968 |
THROMBOCYTOPENIA |
17 |
0.0002 |
| 969 |
FEBRILE NEUTROPENIA |
10 |
0.0002 |
| 970 |
ABORTION SPONTANEOUS |
6 |
0.0001 |
| 971 |
IRRITABILITY |
9 |
0.0001 |
| 972 |
DRUG DEPENDENCE |
24 |
0.0001 |
| 973 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
8 |
0.0001 |
| 974 |
WITHDRAWAL SYNDROME |
6 |
0.0001 |
| 975 |
PLATELET COUNT DECREASED |
15 |
0.0001 |
| 976 |
PRODUCT STORAGE ERROR |
12 |
0.0001 |
| 977 |
MALIGNANT NEOPLASM PROGRESSION |
14 |
0.0001 |
| 978 |
DISEASE PROGRESSION |
16 |
0.0001 |
| 979 |
EMOTIONAL DISTRESS |
16 |
0.0001 |
| 980 |
ACNE |
10 |
0.0001 |
| 981 |
ASPARTATE AMINOTRANSFERASE INCREASED |
7 |
0.0001 |
| 982 |
DRUG DOSE OMISSION BY DEVICE |
10 |
0.0001 |
| 983 |
ADVERSE EVENT |
11 |
0.0001 |
| 984 |
ALANINE AMINOTRANSFERASE INCREASED |
7 |
0.0001 |
| 985 |
SKIN BURNING SENSATION |
8 |
0.0001 |
| 986 |
DRUG ABUSE |
9 |
0.0001 |
| 987 |
INJECTION SITE HAEMORRHAGE |
8 |
0.0001 |
| 988 |
TREATMENT FAILURE |
8 |
0.0001 |
| 989 |
DRUG DOSE OMISSION |
12 |
0.0001 |
| 990 |
TOXICITY TO VARIOUS AGENTS |
10 |
0.0001 |